NO913884L - Kvantitativ analyse som forutsier diabetisk tilstand. - Google Patents

Kvantitativ analyse som forutsier diabetisk tilstand.

Info

Publication number
NO913884L
NO913884L NO91913884A NO913884A NO913884L NO 913884 L NO913884 L NO 913884L NO 91913884 A NO91913884 A NO 91913884A NO 913884 A NO913884 A NO 913884A NO 913884 L NO913884 L NO 913884L
Authority
NO
Norway
Prior art keywords
insulin
micrograms
resistance
quantitative analysis
serum
Prior art date
Application number
NO91913884A
Other languages
English (en)
Other versions
NO303598B1 (no
NO913884D0 (no
Inventor
Alison S Kennington
Joseph Larner
Original Assignee
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia filed Critical Univ Virginia
Publication of NO913884L publication Critical patent/NO913884L/no
Publication of NO913884D0 publication Critical patent/NO913884D0/no
Publication of NO303598B1 publication Critical patent/NO303598B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
NO913884A 1990-02-08 1991-10-03 FremgangsmÕte med kvantitativ analyse som forutsier diabetisk tilstand NO303598B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47695390A 1990-02-08 1990-02-08
PCT/US1991/000655 WO1991012335A1 (en) 1990-02-08 1991-02-06 Quantitative analysis of chiroinositol as a diabetic condition predictor

Publications (3)

Publication Number Publication Date
NO913884L true NO913884L (no) 1991-10-03
NO913884D0 NO913884D0 (no) 1991-10-03
NO303598B1 NO303598B1 (no) 1998-08-03

Family

ID=23893914

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913884A NO303598B1 (no) 1990-02-08 1991-10-03 FremgangsmÕte med kvantitativ analyse som forutsier diabetisk tilstand

Country Status (12)

Country Link
EP (1) EP0468031B1 (no)
JP (1) JP3118458B2 (no)
KR (1) KR0175314B1 (no)
AT (1) ATE151464T1 (no)
AU (2) AU651572B2 (no)
CA (1) CA2051630A1 (no)
DE (1) DE69125536T2 (no)
DK (1) DK0468031T3 (no)
ES (1) ES2101742T3 (no)
GR (1) GR3023760T3 (no)
NO (1) NO303598B1 (no)
WO (1) WO1991012335A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525526A (en) * 1994-02-02 1996-06-11 The University Of Virginia Patent Foundation Immunoassay for inositols
US5550166A (en) * 1995-03-17 1996-08-27 Ostlund; Richard E. Pinitol and derivatives thereof for the treatment of metabolic disorders
WO1998042863A1 (fr) * 1997-03-26 1998-10-01 Asahi Kasei Kogyo Kabushiki Kaisha Procede hautement sensible de dosage du chiro-inositol et compositions destinees au dosage
CA2374269C (en) 1999-05-20 2007-04-24 Humanetics Corporation Stimulating transport of glucose into animal tissue by the administration of pinitol
JP4602577B2 (ja) 2001-03-15 2010-12-22 積水メディカル株式会社 前糖尿病状態のスクリーニング方法及びスクリーニング用試薬

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69024348T2 (de) * 1989-03-08 1996-08-14 Univ Virginia Verfahren zum nachweis des diabetischen zustandes

Also Published As

Publication number Publication date
GR3023760T3 (en) 1997-09-30
CA2051630A1 (en) 1991-08-09
ATE151464T1 (de) 1997-04-15
EP0468031B1 (en) 1997-04-09
DE69125536T2 (de) 1997-07-17
AU662268B2 (en) 1995-08-24
AU7141094A (en) 1994-11-24
KR0175314B1 (ko) 1999-02-01
WO1991012335A1 (en) 1991-08-22
JP3118458B2 (ja) 2000-12-18
AU7253191A (en) 1991-09-03
DK0468031T3 (da) 1997-05-12
ES2101742T3 (es) 1997-07-16
KR920701472A (ko) 1992-08-11
NO303598B1 (no) 1998-08-03
EP0468031A1 (en) 1992-01-29
EP0468031A4 (en) 1991-11-27
DE69125536D1 (de) 1997-05-15
NO913884D0 (no) 1991-10-03
AU651572B2 (en) 1994-07-28
JPH04505218A (ja) 1992-09-10

Similar Documents

Publication Publication Date Title
US6670192B1 (en) Apparatus for combined assay for current glucose level and intermediate or long-term glycemic control
Bürgi et al. One-step sandwich enzyme immunoassay for insulin using monoclonal antibodies
Chan A superior early myocardial infarction marker: human heart-type fatty acid-binding protein
JONES et al. 5.2 MEASURING BLOOD-ALCOHOL CONCENTRATION FOR CLINICAL AND FORENSIC PURPOSES
Jinchuan et al. Upregulation of CD40–CD40 ligand system in patients with diabetes mellitus
Vreman et al. Analysis for carboxyhemoglobin by gas chromatography and multicomponent spectrophotometry compared.
Engbaek et al. Enzyme immunoassay of hemoglobin A1c: analytical characteristics and clinical performance for patients with diabetes mellitus, with and without uremia.
Cefalu et al. Validity of serum fructosamine as index of short-term glycemic control in diabetic outpatients
Rosenthal et al. Sex-and age-related differences in bilirubin concentrations in serum.
BR9915384A (pt) Métodos para detecção da presença de sangue em uma amostra biológica, para detecção de sangramento gastrointestinal inferior, para detecção de sangramento no trato gastrointestinal superior, para diagnosticar condições de doença e para detecção da presença de um analito em uma amostra biológica
Collinson et al. Cardiac troponin T in renal disease
Johnson et al. Relationship between albumin and fructosamine concentration in diabetic and non-diabetic sera
NO913884D0 (no) Kvantitativ analyse som forutsier diabetisk tilstand.
Kordonouri et al. Quantitative assessment of urinary protein and enzyme excretion—a diagnostic programme for the detection of renal involvement in type I diabetes mellitus
KR100602952B1 (ko) 면역크로마토그래피법을 이용한 당화혈색소 측정센서
Hickman Precautions in Using an internal Standard to Measure Pyridinoiine and Deoxypyridinoline In Urine
Yuan et al. The association between self-monitoring of blood glucose and HbA1c in type 2 diabetes
Morin et al. Nonenzymatic glycation of immunoglobulins does not impair antigen-antibody binding.
Agardh et al. Urinary N-acetyl-β-D-glucosaminidase activity does not predict development of diabetic nephropathy
Cunningham Phenylketonuria testing-its role in pediatrics and public health
Vashist et al. Glycated haemoglobin (HbA1c) monitoring for diabetes diagnosis, management and therapy
Gambhir et al. Insulin receptor defect in diabetic man with chronic renal failure: A comparison of erythrocyte insulin binding in diabetic and nondiabetic patients on maintenance hemodialysis
US20120301897A1 (en) Acetaminophen-protein adduct assay device and method
Schnedl et al. Hemoglobin D [β 121 (GH4) Glu→ Gln] causing falsely low and high HbA1C values in HPLC
Boonprasert et al. Electrochemical-biosensor Microchip Based on Gold Nanoparticles as a Point-of-Care Test (POCT) for Quantitative Determination of Glycated Hemoglobin (HbA1c)